ArticleiScience2021
The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma.
Dhananjaya Pal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleiScience2021
Dhananjaya Pal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.